Anna Brown

Reporter at @endpts | [email protected] | Signal: annabrown.04

[Drew Armstrong @ArmstrongDrew]

🔎As astute readers of @endpts know, our UK-based reporter @annajbwn scooped the UK-US drug price/trade deal and details last week:

https://t.co/BRVgYQ0QWS

[Drew Armstrong @ArmstrongDrew]

🎙️Let's talk "most favored nation"!

Today on Post-Hoc Live, I'll be joined by biotech lobbyist Nick Shipley to unpack the last 24 hours of Trump's drug pricing exec order, how it would work (or not), unintended consequences + what happens next. Join us!

https://t.co/ypUtgNlqzz

[Drew Armstrong @ArmstrongDrew]

🎙️Let's talk tariffs!

Tomorrow, we're going to bring our newsroom direct to you at 12 p.m. ET for Post-Hoc Live, talking about how pharma is reacting to Trump's "Liberation Day" announcement. Join us!

https://t.co/7ZoRMfOxuN

[Max Bayer @maxonwifi]

Don't get me wrong, I like writing, but I'm really a professional yapper. And tomorrow is showtime with the first @endpts Post-Hoc Live!

@ArmstrongDrew, @annajbwn and myself are talking TARIFFS. We can't wait to dish and dissect how pharmas are reacting. https://t.co/QpA53HFmeS

[Andrew Dunn @AndrewE_Dunn]

Here's something new: our first-ever Post-Hoc Live happens tomorrow at noon ET

Watch @ArmstrongDrew, @maxonwifi, and @annajbwn talk pharma & tariffs ... and doing it live:
https://t.co/FISHJTNCk0

[Anna Brown @annajbwn]

Pharma tariffs are likely to leave little room to hide for companies as the 232 investigation hits all the major parts of the supply chain: https://t.co/meKkHxvZmR

[Max Bayer @maxonwifi]

Section 232 investigation on pharma products confirmed. Sector tariffs inch closer. For @endpts: https://t.co/eUGb1jiLX6

[Endpoints News @endpts]

Legend Biotech is ramping up Carvykti production as it eyes blockbuster status in 2025, following $963M in sales last year. https://t.co/9FXtQkqWVl

[Drew Armstrong @ArmstrongDrew]

The @endpts Health Tech newsletter is a @SABEW winner! Congrats to @lydiapflanzer, @ShelbyJLiv + @nyeungs for building an amazing, smart product that keep the industry informed!

[Anna Brown @annajbwn]

EMA blocks drug production at Serra Pamies Spanish facility due to manufacturing and management issues:

https://t.co/Hn8hNeb1ww

[Lia DeGroot @lia_degroot]

I sat down with FDA's Peter Marks over Zoom yesterday to talk accelerated approvals, rare disease and what he wants to focus on over the next few years

Read it here: https://t.co/s3F0iibTwL

[Anna Brown @annajbwn]

Tetra Pharm Technologies opens new headquarters to boost cannabinoid drug research and manufacturing:

https://t.co/2YUTBxFetU

[Anna Brown @annajbwn]

First @endpts byline:

MediWound has delayed the US launch of its topical gel for burns to early next year due to a manufacturing “deviation.” The commercial launch was initially planned for this September.

https://t.co/gs5TboPWMA

[Anna Brown @annajbwn]

Excited to be joining the Endpoints News team!

[Drew Armstrong @ArmstrongDrew]

👋A very big @endpts welcome to @annajbwn in London!

Anna is our latest addition to the newsroom, and will be covering pharma + manufacturing, working closely with @reynaldendpts + @AmberTongPW.

Give her a follow and a hello!

[nature @Nature]

A widely used tuberculosis vaccine failed to prevent COVID-19 in health-care workers who were enrolled in a large trial conducted at the height of the pandemic. https://t.co/JubSXeVgjk

[Anna Brown @annajbwn]

Pfizer says its mRNA-based influenza program, in collaboration with BioNTech, has the potential to succeed current vaccination technologies.

https://t.co/JmFqxsIqtH

#Pfizer #mRNA #biotech

[Anna Brown @annajbwn]

President Nana Addo Dankwa Afkufo-Addo has announced the construction of Ghana’s first vaccine manufacturing facility.

#biotech #vaccines #africanvacation

https://t.co/V8aG2fQb28